Longitudinal Progression Prediction of Alzheimer's Disease with Tabular Foundation Model
Yilang Ding, Jiawen Ren, Jiaying Lu, Gloria Hyunjung Kwak, Armin Iraji, Shengpu Tang, Alex Fedorov
TL;DR
This work tackles the challenge of forecasting Alzheimer’s disease progression from multimodal longitudinal data by introducing L2C-TabPFN, which first converts irregular longitudinal records into fixed-length cross-sectional vectors via a longitudinal-to-cross-sectional transformation and then applies a TabPFN pretrained on synthetic tabular data with in-context learning. The approach is evaluated on the TADPOLE dataset, focusing on three outcomes: diagnostic status, cognitive scores, and ventricular volume, with ventricular volume emerging as the strongest area of predictive gain. Compared with the Frog baseline (an XGBoost-based method), L2C-TabPFN achieves competitive performance on diagnosis and cognition but delivers state-of-the-art accuracy for ventricular volume forecasting, highlighting the promise of transformer-based tabular models for imaging biomarker prediction. SHAP-based interpretability analyses show clinically relevant feature contributions and reveal task-dependent attribution patterns, underscoring the practical potential and interpretability of using tabular foundation models for longitudinal Alzheimer's disease prediction.
Abstract
Alzheimer's disease is a progressive neurodegenerative disorder that remains challenging to predict due to its multifactorial etiology and the complexity of multimodal clinical data. Accurate forecasting of clinically relevant biomarkers, including diagnostic and quantitative measures, is essential for effective monitoring of disease progression. This work introduces L2C-TabPFN, a method that integrates a longitudinal-to-cross-sectional (L2C) transformation with a pre-trained Tabular Foundation Model (TabPFN) to predict Alzheimer's disease outcomes using the TADPOLE dataset. L2C-TabPFN converts sequential patient records into fixed-length feature vectors, enabling robust prediction of diagnosis, cognitive scores, and ventricular volume. Experimental results demonstrate that, while L2C-TabPFN achieves competitive performance on diagnostic and cognitive outcomes, it provides state-of-the-art results in ventricular volume prediction. This key imaging biomarker reflects neurodegeneration and progression in Alzheimer's disease. These findings highlight the potential of tabular foundational models for advancing longitudinal prediction of clinically relevant imaging markers in Alzheimer's disease.
